Cell Banking Outsourcing Market By Bank Type (Master Cell Banking, Working Cell Banking, Viral Cell Banking), By Cell Type (Stem Cell Banking, Non-Stem Cell Banking), By Application (Cell Bank Storage, Cell Bank Preparation, Bank Characterization & Testing), and Region (North America, Europe, Asia-Pacific, Rest of the World) - Forecast to 2032.

TABLE OF CONTENTS

1. REPORT PROLOGUE

2. MARKET INTRODUCTION

2.1. Definition

2.2. Scope of the Study

2.2.1. Research Objective

2.2.2. Assumptions

2.2.3. Limitations

3. RESEARCH METHODOLOGY

3.1. Overview

3.2. Data Mining

3.3. Secondary Research

3.4. Primary Research

3.4.1. Primary Interviews and Information Gathering Process

3.4.2. Breakdown of Primary Respondents

3.5. Forecasting Techniques

3.6. Market Size Estimation

3.6.1. Bottom-Up Approach

3.6.2. Top-Down Approach

3.7. Data Triangulation

3.8. Validation

4. MARKET DYNAMICS

4.1. Overview

4.2. Drivers

4.3. Restraints

4.4. Opportunities

5. MARKET FACTOR ANALYSIS

5.1. Porter’s Five Forces Analysis

5.1.1. Bargaining Power of Suppliers

5.1.2. Bargaining Power of Buyers

5.1.3. Threat of New Entrants

5.1.4. Threat of Substitutes

5.1.5. Intensity of Rivalry

5.2. Value Chain Analysis

5.3. COVID-19 Impact Analysis

5.3.1. Market Impact Analysis

5.3.2. Impact on R&D

5.3.3. Regional Impact

5.3.4. Impact on Market Growth

6. GLOBAL CELL BANKING OUTSOURCING MARKET, BY BANK TYPE

6.1. Overview

6.2. Master Cell Banking

Market Estimates & Forecast, by Region, 2018–2027

Market Estimates & Forecast, by Country, 2018–2027

6.3. Working Cell Banking

Market Estimates & Forecast, by Region, 2018–2027

Market Estimates & Forecast, by Country, 2018–2027

6.4. Viral Cell Banking

Market Estimates & Forecast, by Region, 2018–2027

Market Estimates & Forecast, by Country, 2018–2027

7. GLOBAL CELL BANKING OUTSOURCING MARKET, BY CELL TYPE

7.1. Overview

7.2. Stem Cell Banking

Market Estimates & Forecast, by Region, 2018–2027

Market Estimates & Forecast, by Country, 2018–2027

7.2.1. Cord Stem Cell Banking

7.2.2. Embryonic Stem Cell Banking

7.2.3. Adult Stem Cell Banking

7.2.4. Dental Stem Cell Banking

7.2.5. IPS Stem Cell Banking

7.3. Non-Stem Cell Banking

Market Estimates & Forecast, by Region, 2018–2027

Market Estimates & Forecast, by Country, 2018–2027

8. GLOBAL CELL BANKING OUTSOURCING MARKET, BY APPLICATION

8.1. Overview

8.2. Cell Bank Storage

Market Estimates & Forecast, by Region, 2018–2027

Market Estimates & Forecast, by Country, 2018–2027

8.2.1. Master Cell Bank Storage

8.2.2. Working Cell Bank Storage

8.2.3. Cell Storage Stability Testing

8.3. Cell Bank Preparation

Market Estimates & Forecast, by Region, 2018–2027

Market Estimates & Forecast, by Country, 2018–2027

8.3.1. Master Cell Bank Preparation

8.3.2. Working Cell Bank Preparation

8.4. Bank Characterization & Testing

Market Estimates & Forecast, by Region, 2018–2027

Market Estimates & Forecast, by Country, 2018–2027

8.4.1. Viral Cell Bank Safety Testing

8.4.2. Microbial Cell Bank Safety Testing

8.4.3. Gene Expression Testing

8.4.4. Karyology Testing

8.4.5. Gene Sequencing Testing

9. GLOBAL CELL BANKING OUTSOURCING MARKET, BY REGION

9.1. Overview

9.2. North America

9.2.1. US

9.2.2. Canada

9.3. Europe

9.3.1. Germany

9.3.2. France

9.3.3. Italy

9.3.4. Spain

9.3.5. UK

9.3.6. Rest of Europe

9.4. Asia-Pacific

9.4.1. Japan

9.4.2. China

9.4.3. India

9.4.4. Australia

9.4.5. South Korea

9.4.6. Rest of Asia-Pacific

9.5. Rest of the World

9.5.1. Middle East

9.5.2. Africa

9.5.3. Latin America

10. COMPANY LANDSCAPE

10.1. Overview

10.2. Competitive Analysis

10.3. Market Share Analysis

10.4. Major Growth Strategy in the Global Cell Banking Outsourcing Market

10.5. Competitive Benchmarking

10.6. Leading Players in Terms of Number of Developments in the Global Cell Banking Outsourcing Market

10.7. Key developments and Growth Strategies

10.7.1. New Product Launch/Service Deployment

10.7.2. Merger &Acquisitions

10.7.3. Joint Ventures

10.8. Major Players Financial Matrix

10.8.1. Sales & Operating Income, 2020

10.8.2. Major Players R&D Expenditure, 2020

11. COMPANY PROFILES

11.1. CordLife

11.1.1. Company Overview

11.1.2. Products Offered

11.1.3. Financial Overview

11.1.4. Key Developments

11.1.5. SWOT Analysis

11.1.6. Key Strategies

11.2. Cleancells

11.2.1. Company Overview

11.2.2. ProductsOffered

11.2.3. Financial Overview

11.2.4. Key Developments

11.2.5. SWOT Analysis

11.2.6. Key Strategies

11.3. Charles River Laboratories

11.3.1. Company Overview

11.3.2. Products Offered

11.3.3. Financial Overview

11.3.4. Key Developments

11.3.5. SWOT Analysis

11.3.6. Key Strategies

11.4. BSL Bioservice

11.4.1. Company Overview

11.4.2. Products Offered

11.4.3. Financial Overview

11.4.4. Key Developments

11.4.5. SWOT Analysis

11.4.6. Key Strategies

11.5. BioReliance

11.5.1. Company Overview

11.5.2. Products Offered

11.5.3. Financial Overview

11.5.4. Key Developments

11.5.5. SWOT Analysis

11.5.6. Key Strategies

11.6. Sartorius

11.6.1. Company Overview

11.6.2. Products Offered

11.6.3. Financial Overview

11.6.4. Key Developments

11.6.5. SWOT Analysis

11.6.6. Key Strategies

11.7. Covance

11.7.1. Company Overview

11.7.2. Products Offered

11.7.3. Financial Overview

11.7.4. Key Developments

11.7.5. SWOT Analysis

11.7.6. Key Strategies

11.8. LifeCell International Pvt. Ltd.

11.8.1. Company Overview

11.8.2. Products Offered

11.8.3. Financial Overview

11.8.4. Key Developments

11.8.5. SWOT Analysis

11.8.6. Key Strategies

11.9. Goodwin Biotechnology Inc.

11.9.1. Company Overview

11.9.2. Products Offered

11.9.3. Financial Overview

11.9.4. Key Developments

11.9.5. SWOT Analysis

11.9.6. Key Strategies

11.10. GlobalStem Inc.

11.10.1. Company Overview

11.10.2. Products Offered

11.10.3. Financial Overview

11.10.4. Key Developments

11.10.5. SWOT Analysis

11.10.6. Key Strategies

11.11. Cryo-Cell International Inc.

11.11.1. Company Overview

11.11.2. Products Offered

11.11.3. Financial Overview

11.11.4. Key Developments

11.11.5. SWOT Analysis

11.11.6. Key Strategies

11.12. Lonza

11.12.1. Company Overview

11.12.2. Products Offered

11.12.3. Financial Overview

11.12.4. Key Developments

11.12.5. SWOT Analysis

11.12.6. Key Strategies

11.13. PX'Therapeutics SA

11.13.1. Company Overview

11.13.2. Products Offered

11.13.3. Financial Overview

11.13.4. Key Developments

11.13.5. SWOT Analysis

11.13.6. Key Strategies

11.14. Wuxi Apptec

11.14.1. Company Overview

11.14.2. Products Offered

11.14.3. Financial Overview

11.14.4. Key Developments

11.14.5. SWOT Analysis

11.14.6. Key Strategies

11.15. SGS Life Sciences

11.15.1. Company Overview

11.15.2. Products Offered

11.15.3. Financial Overview

11.15.4. Key Developments

11.15.5. SWOT Analysis

11.15.6. Key Strategies

12. APPENDIX

12.1. References

12.2. Related Reports

LIST OF TABLES

TABLE 1 GLOBAL CELL BANKING OUTSOURCING MARKET SYNOPSIS, 2018–2027

TABLE 2 GLOBAL CELL BANKING OUTSOURCING MARKET ESTIMATES &FORECAST, 2018–2027(USD MILLION)

TABLE 3 GLOBAL CELL BANKING OUTSOURCING MARKET, BYBANK TYPE, 2018–2027 (USD MILLION)

TABLE 4 GLOBAL CELL BANKING OUTSOURCING MARKET, BY CELL TYPE, 2018–2027 (USD MILLION)

TABLE 5 GLOBAL CELL BANKING OUTSOURCING MARKET, BY APPLICATION, 2018–2027 (USD MILLION)

TABLE 6 NORTH AMERICA: CELL BANKING OUTSOURCING MARKET, BY BANK TYPE, 2018–2027 (USD MILLION)

TABLE 7 NORTH AMERICA CELL BANKING OUTSOURCING MARKET, BY CELL TYPE, 2018–2027 (USD MILLION)

TABLE 8 NORTH AMERICA: CELL BANKING OUTSOURCING MARKET, BY APPLICATION, 2018–2027 (USD MILLION)

TABLE 9 US: CELL BANKING OUTSOURCING MARKET, BY BANK TYPE, 2018–2027 (USD MILLION)

TABLE 10 US CELL BANKING OUTSOURCING MARKET, BY CELL TYPE, 2018–2027 (USD MILLION)

TABLE 11 US: CELL BANKING OUTSOURCING MARKET, BY APPLICATION, 2018–2027 (USD MILLION)

TABLE 12 CANADA: CELL BANKING OUTSOURCING MARKET, BY BANK TYPE, 2018–2027 (USD MILLION)

TABLE 13 CANADA CELL BANKING OUTSOURCING MARKET, BY CELL TYPE, 2018–2027 (USD MILLION)

TABLE 14 CANADA: CELL BANKING OUTSOURCING MARKET, BY APPLICATION, 2018–2027 (USD MILLION)

TABLE 15 EUROPE: CELL BANKING OUTSOURCING MARKET, BY BANK TYPE, 2018–2027 (USD MILLION)

TABLE 16 EUROPE: CELL BANKING OUTSOURCING MARKET, BY CELL TYPE, 2018–2027 (USD MILLION)

TABLE 17 EUROPE: CELL BANKING OUTSOURCING MARKET, BY APPLICATION, 2018–2027 (USD MILLION)

TABLE 18 GERMANY: CELL BANKING OUTSOURCING MARKET, BY BANK TYPE,, 2018–2027 (USD MILLION)

TABLE 19 GERMANY: CELL BANKING OUTSOURCING MARKET, BY CELL TYPE, 2018–2027 (USD MILLION)

TABLE 20 GERMANY: CELL BANKING OUTSOURCING MARKET, BY APPLICATION, 2018–2027 (USD MILLION)

TABLE 21 UK: CELL BANKING OUTSOURCING MARKET, BY BANK TYPE, 2018–2027 (USD MILLION)

TABLE 22 UK: CELL BANKING OUTSOURCING MARKET, BY CELL TYPE, 2018–2027 (USD MILLION)

TABLE 23 UK: CELL BANKING OUTSOURCING MARKET, BY APPLICATION, 2018–2027 (USD MILLION)

TABLE 24 FRANCE: CELL BANKING OUTSOURCING MARKET, BY BANK TYPE, 2018–2027 (USD MILLION)

TABLE 25 FRANCE: CELL BANKING OUTSOURCING MARKET, BY CELL TYPE, 2018–2027 (USD MILLION)

TABLE 26 FRANCE: CELL BANKING OUTSOURCING MARKET, BY APPLICATION, 2018–2027 (USD MILLION)

TABLE 27 ITALY: CELL BANKING OUTSOURCING MARKET, BY BANK TYPE, 2018–2027 (USD MILLION)

TABLE 28 ITALY: CELL BANKING OUTSOURCING MARKET, BY CELL TYPE, 2018–2027 (USD MILLION)

TABLE 29 ITALY: CELL BANKING OUTSOURCING MARKET, BY APPLICATION, 2018–2027 (USD MILLION)

TABLE 30 SPAIN: CELL BANKING OUTSOURCING MARKET, BY BANK TYPE, 2018–2027 (USD MILLION)

TABLE 31 SPAIN: CELL BANKING OUTSOURCING MARKET, BY CELL TYPE, 2018–2027 (USD MILLION)

TABLE 32 SPAIN: CELL BANKING OUTSOURCING MARKET, BY APPLICATION, 2018–2027 (USD MILLION)

TABLE 33 REST OF EUROPE: CELL BANKING OUTSOURCING MARKET, BY BANK TYPE,, 2018–2027 (USD MILLION)

TABLE 34 REST OF EUROPE: CELL BANKING OUTSOURCING MARKET, BY CELL TYPE, 2018–2027 (USD MILLION)

TABLE 35 REST OF EUROPE: CELL BANKING OUTSOURCING MARKET, BY APPLICATION, 2018–2027 (USD MILLION)

TABLE 36 ASIA-PACIFIC: CELL BANKING OUTSOURCING MARKET, BY BANK TYPE, 2018–2027 (USD MILLION)

TABLE 37 ASIA-PACIFIC: CELL BANKING OUTSOURCING MARKET, BY CELL TYPE, 2018–2027 (USD MILLION)

TABLE 38 ASIA-PACIFIC: CELL BANKING OUTSOURCING MARKET, BY APPLICATION, 2018–2027 (USD MILLION)

TABLE 39 INDIA: CELL BANKING OUTSOURCING MARKET, BY BANK TYPE, 2018–2027 (USD MILLION)

TABLE 40 INDIA: CELL BANKING OUTSOURCING MARKET, BY CELL TYPE, 2018–2027 (USD MILLION)

TABLE 41 INDIA: CELL BANKING OUTSOURCING MARKET, BY APPLICATION, 2018–2027 (USD MILLION)

TABLE 42 CHINA: CELL BANKING OUTSOURCING MARKET, BY BANK TYPE, 2018–2027 (USD MILLION)

TABLE 43 CHINA: CELL BANKING OUTSOURCING MARKET, BY CELL TYPE, 2018–2027 (USD MILLION)

TABLE 44 CHINA: CELL BANKING OUTSOURCING MARKET, BY APPLICATION, 2018–2027 (USD MILLION)

TABLE 45 JAPAN: CELL BANKING OUTSOURCING MARKET, BY BANK TYPE, 2018–2027 (USD MILLION)

TABLE 46 JAPAN: CELL BANKING OUTSOURCING MARKET, BY CELL TYPE, 2018–2027 (USD MILLION)

TABLE 47 JAPAN: CELL BANKING OUTSOURCING MARKET, BY APPLICATION, 2018–2027 (USD MILLION)

TABLE 48 SOUTH KOREA:CELL BANKING OUTSOURCING MARKET, BY BANK TYPE, 2018–2027 (USD MILLION)

TABLE 49 SOUTH KOREA: CELL BANKING OUTSOURCING MARKET, BY CELL TYPE, 2018–2027 (USD MILLION)

TABLE 50 SOUTH KOREA: CELL BANKING OUTSOURCING MARKET, BY APPLICATION, 2018–2027 (USD MILLION)

TABLE 51 AUSTRALIA: CELL BANKING OUTSOURCING MARKET, BY BANK TYPE, 2018–2027 (USD MILLION)

TABLE 52 AUSTRALIA: CELL BANKING OUTSOURCING MARKET, BY CELL TYPE, 2018–2027 (USD MILLION)

TABLE 53 AUSTRALIA: CELL BANKING OUTSOURCING MARKET, BY SOURCE, 2018–2027 (USD MILLION)

TABLE 54 AUSTRALIA: CELL BANKING OUTSOURCING MARKET, BY APPLICATION, 2018–2027 (USD MILLION)

TABLE 55 REST OF ASIA-PACIFIC: CELL BANKING OUTSOURCING MARKET, BY BANK TYPE, 2018–2027 (USD MILLION)

TABLE 56 REST OF ASIA-PACIFIC: CELL BANKING OUTSOURCING MARKET, BY CELL TYPE, 2018–2027 (USD MILLION)

TABLE 57 REST OF ASIA-PACIFIC: CELL BANKING OUTSOURCING MARKET, BY APPLICATION, 2018–2027 (USD MILLION)

TABLE 58 REST OF THE WORLD: CELL BANKING OUTSOURCING MARKET, BY BANK TYPE, 2018–2027 (USD MILLION)

TABLE 59 REST OF THE WORLD: CELL BANKING OUTSOURCING MARKET, CELL TYPE,2018–2027 (USD MILLION)

TABLE 60 REST OF THE WORLD: CELL BANKING OUTSOURCING MARKET, APPLICATION, 2018–2027 (USD MILLION)

TABLE 61 MIDDLE EAST: CELL BANKING OUTSOURCING MARKET, BY BANK TYPE, 2018–2027 (USD MILLION)

TABLE 62 MIDDLE EAST: CELL BANKING OUTSOURCING MARKET, CELL TYPE,2018–2027 (USD MILLION)

TABLE 63 MIDDLE EAST: CELL BANKING OUTSOURCING MARKET, APPLICATION, 2018–2027 (USD MILLION)

TABLE 64 AFRICA: CELL BANKING OUTSOURCING MARKET, BY BANK TYPE, 2018–2027 (USD MILLION)

TABLE 65 AFRICA: CELL BANKING OUTSOURCING MARKET, CELL TYPE,2018–2027 (USD MILLION)

TABLE 66 AFRICA: CELL BANKING OUTSOURCING MARKET, APPLICATION, 2018–2027 (USD MILLION)

TABLE 67 LATIN AMERICA: CELL BANKING OUTSOURCING MARKET, BY BANK TYPE, 2018–2027 (USD MILLION)

TABLE 68 LATIN AMERICA: CELL BANKING OUTSOURCING MARKET, CELL TYPE,2018–2027 (USD MILLION)

TABLE 69 LATIN AMERICA: CELL BANKING OUTSOURCING MARKET, APPLICATION, 2018–2027 (USD MILLION)

LIST OF FIGURES

FIGURE 1 RESEARCH PROCESS

FIGURE 2 MARKET STRUCTURE FOR THE GLOBAL CELL BANKING OUTSOURCING MARKET

FIGURE 3 MARKET DYNAMICS FOR THE GLOBAL CELL BANKING OUTSOURCING MARKET

FIGURE 4 GLOBAL CELL BANKING OUTSOURCING MARKET SHARE, BY BANK TYPE, 2020 (%)

FIGURE 5 GLOBAL CELL BANKING OUTSOURCING MARKET SHARE, BY CELL TYPE, 2020 (%)

FIGURE 6 GLOBAL CELL BANKING OUTSOURCING MARKET SHARE, BY APPLICATION, 2020 (%)

FIGURE 7 GLOBAL CELL BANKING OUTSOURCING MARKET SHARE, BY REGION, 2020 (%)

FIGURE 8 NORTH AMERICA: CELL BANKING OUTSOURCING MARKET SHARE, BY REGION, 2020 (%)

FIGURE 9 EUROPE: CELL BANKING OUTSOURCING MARKET SHARE, BY REGION, 2020 (%)

FIGURE 10 ASIA-PACIFIC: CELL BANKING OUTSOURCING MARKET SHARE, BY REGION, 2020 (%)

FIGURE 11 REST OF THE WORLD: CELL BANKING OUTSOURCING MARKET SHARE, BY REGION, 2020 (%)

FIGURE 12 GLOBAL CELL BANKING OUTSOURCING MARKET: COMPANY SHARE ANALYSIS, 2020 (%)

FIGURE 13 CORDLIFE: KEY FINANCIALS

FIGURE 14 CORDLIFE: SEGMENTAL REVENUE

FIGURE 15 CORDLIFE: REGIONAL REVENUE

FIGURE 16 CLEANCELLS: KEY FINANCIALS

FIGURE 17 CLEANCELLS: SEGMENTAL REVENUE

FIGURE 18 CLEANCELLS: REGIONAL REVENUE

FIGURE 19 CHARLES RIVER LABORATORIES: KEY FINANCIALS

FIGURE 20 CHARLES RIVER LABORATORIES: SEGMENTAL REVENUE

FIGURE 21 CHARLES RIVER LABORATORIES: REGIONAL REVENUE

FIGURE 22 BSL BIOSERVICE: KEY FINANCIALS

FIGURE 23 BSL BIOSERVICE: SEGMENTAL REVENUE

FIGURE 24 BSL BIOSERVICE: REGIONAL REVENUE

FIGURE 25 BIORELIANCE CORPORATION: KEY FINANCIALS

FIGURE 26 BIORELIANCE: SEGMENTAL REVENUE

FIGURE 27 BIORELIANCE: REGIONAL REVENUE

FIGURE 28 SARTORIUS: KEY FINANCIALS

FIGURE 29 SARTORIUS: SEGMENTAL REVENUE

FIGURE 30 SARTORIUS: REGIONAL REVENUE

FIGURE 31 COVANCE: KEY FINANCIALS

FIGURE 32 COVANCE: SEGMENTAL REVENUE

FIGURE 33 COVANCE: REGIONAL REVENUE

FIGURE 34 LIFECELL INTERNATIONAL PVT. LTD.: KEY FINANCIALS

FIGURE 35 LIFECELL INTERNATIONAL PVT. LTD.: SEGMENTAL REVENUE

FIGURE 36 LIFECELL INTERNATIONAL PVT. LTD.: REGIONAL REVENUE

FIGURE 37 GOODWIN BIOTECHNOLOGY INC.: KEY FINANCIALS

FIGURE 38 GOODWIN BIOTECHNOLOGY INC.: SEGMENTAL REVENUE

FIGURE 39 GOODWIN BIOTECHNOLOGY INC.: REGIONAL REVENUE

FIGURE 40 GLOBALSTEM INC.: KEY FINANCIALS

FIGURE 41 GLOBALSTEM INC.: SEGMENTAL REVENUE

FIGURE 42 GLOBALSTEM INC.: REGIONAL REVENUE

FIGURE 43 CRYO-CELL INTERNATIONAL INC.: KEY FINANCIALS

FIGURE 44 CRYO-CELL INTERNATIONAL INC.: SEGMENTAL REVENUE

FIGURE 45 CRYO-CELL INTERNATIONAL INC.: REGIONAL REVENUE

FIGURE 46 LONZA: KEY FINANCIALS

FIGURE 47 LONZA: SEGMENTAL REVENUE

FIGURE 48 LONZA: REGIONAL REVENUE

FIGURE 49 PX'THERAPEUTICS SA: KEY FINANCIALS

FIGURE 50 PX'THERAPEUTICS SA: SEGMENTAL REVENUE

FIGURE 51 PX'THERAPEUTICS SA: REGIONAL REVENUE

FIGURE 52 WUXI APPTEC: KEY FINANCIALS

FIGURE 53 WUXI APPTEC: SEGMENTAL REVENUE

FIGURE 54 WUXI APPTEC: REGIONAL REVENUE

FIGURE 55 SGS LIFE SCIENCES: KEY FINANCIALS

FIGURE 56 SGS LIFE SCIENCES: SEGMENTAL REVENUE

FIGURE 57 SGS LIFE SCIENCES: REGIONAL REVENUE